Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCannabis Strategic Ventures

Cannabis Strategic Ventures

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0042 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
362753
Market Cap
0.00M

Momentum Score

…

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cannabis Strategic Ventures (ticker NUGS on OTC Pink) has limited public disclosure and identifies as an investment vehicle targeting opportunities in cannabis and ancillary sectors. Its long-term upside could be supported by state-level legalization, growth in consumer and ancillary markets, and successful capital deployment, offering small-cap exposure to the industry for investors accepting high information risk.

Material risks include minimal regulatory and financial transparency, low trading liquidity of a Pink-listed microcap, significant execution and financing risk, and exposure to U.S. cannabis regulatory uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
14.60M
Revenue Per Share
0.05
Gross Profit TTM
2.78M
Debt / Equity
-3.73
ROE
-
Net Debt
20.96M
ROCE
-286.77%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Type yearly yearly yearly yearly yearly
Date 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Income before tax - -9.08M -21.43M -0.62M 0.09M
Minority interest - -0.02M -0.02M - -
Net income - -9.06M -21.43M -0.62M 0.09M
Selling general administrative - 7.44M 21.14M 4.70M 0.02M
Gross profit - 0.48M 0.02M 0.25M 0.00M
Reconciled depreciation - 0.13M - - -
Ebit -5.30M -7.43M -21.12M -4.45M -0.02M
Ebitda - -7.29M -21.12M -4.44M -0.12M
Depreciation and amortization - 0.13M - 0.01M -0.10M
Operating income - -8.58M -21.12M -4.45M -0.02M
Other operating expenses - 9.33M 21.82M 4.79M 0.02M
Interest expense 0.00M 0.04M 0.00M 0.00M 0.00M
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - - - 0.01M 0.00M
Net interest income - -0.04M 0.00M 0.01M 0.00M
Income tax expense - -0.44M - 0.00M 0.00M
Total revenue - 2.37M 0.70M 0.34M 0.00M
Total operating expenses - 7.44M 21.14M 4.70M 0.02M
Cost of revenue - 1.89M 0.68M 0.10M 0.00M
Total other income expense net - -2.07M -0.32M 3.82M 0.10M
Net income from continuing ops - -9.08M -21.43M -0.62M 0.09M
Net income applicable to common shares -5.64M -9.06M -21.43M - 0.09M
Breakdown 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Type yearly yearly yearly yearly yearly
Date 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Total assets - 17.74M 2.84M 12.44M 0.00M
Other current assets 0.08M 0.05M 0.06M - -
Total liab - 23.51M 2.41M 1.74M 0.05M
Total stockholder equity - -5.75M 0.42M 10.70M -0.05M
Other current liab 0.64M 0.96M 1.64M 0.06M 0.02M
Common stock 0.29M 0.27M 0.18M 0.31M 0.03M
Capital stock - 0.28M 0.18M - -
Retained earnings -51.21M -45.62M -36.57M -5.45M -4.79M
Other assets 1.07M 1.07M 1.04M - -
Cash - 0.49M 0.07M 0.35M 0.00M
Total current liabilities 18.55M 15.89M 2.41M 0.15M 0.05M
Current deferred revenue - 0.27M 0.78M - -
Net debt - 20.96M 0.55M -0.35M -
Short term debt - 13.83M 0.62M - -
Short long term debt - 12.08M 0.62M - -
Short long term debt total - 21.45M 0.62M - -
Other stockholder equity 2.02M 39.59M 36.81M 15.84M 4.72M
Property plant equipment 10.90M 12.07M 0.03M - -
Total current assets 3.91M 4.46M 1.17M 4.19M 0.00M
Long term investments - 0.03M 0.50M - -
Net tangible assets -8.04M -5.86M 0.32M - -0.05M
Net receivables 0.31M 0.85M 0.67M 0.68M -
Inventory 3.09M 2.99M 0.37M - -
Accounts payable 1.37M 1.11M 0.15M 0.09M 0.03M
Non currrent assets other - 1.07M 1.04M 8.25M 0.00M
Non current assets total - 13.28M 1.67M 8.25M 0.00M
Capital lease obligations - 9.38M - - -
Breakdown 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Type yearly yearly yearly yearly yearly
Date 2021-03-31 2020-03-31 2019-03-31 2018-03-31 2017-03-31
Investments - -3.40M -0.14M -0.37M -
Change to liabilities 0.27M 1.00M 0.74M - 0.00M
Total cashflows from investing activities -0.82M -3.40M -0.14M - -
Net borrowings 3.46M 11.45M 0.62M - 0.02M
Total cash from financing activities 4.76M 11.46M 2.35M 1.24M 0.02M
Change to operating activities 0.15M 0.19M -1.47M - -
Net income -5.64M -9.08M -21.43M -0.62M 0.09M
Change in cash -0.15M 0.41M -0.33M 0.35M -0.00M
Begin period cash flow 0.49M 0.07M 0.40M 0.00M 0.00M
End period cash flow - 0.49M 0.07M 0.35M 0.00M
Total cash from operating activities -4.09M -7.64M -2.53M -0.52M -0.02M
Issuance of capital stock - 0.01M 1.73M - -
Depreciation 0.37M 0.13M 0.13M - -
Other cashflows from investing activities -0.00M -0.00M -0.01M - -
Change to inventory -0.10M -3.08M -0.43M - -
Change to account receivables 0.24M -0.42M -0.04M -0.30M -
Other cashflows from financing activities - 11.45M 0.61M 0.30M 0.02M
Change to netincome 0.62M 3.58M 19.67M - -0.10M
Capital expenditures 0.81M 3.40M 0.03M 0.00M 0.00M
Change in working capital - -2.30M -0.77M -0.29M 0.00M
Stock based compensation - 1.50M 19.34M 4.20M -
Other non cash items - 2.11M 0.33M -3.82M -0.10M
Free cash flow - -11.05M -2.57M -0.52M -0.02M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NUGS
Cannabis Strategic Ventures		 -
-%		 0.00 - - 0.00 113.91 4.56 -3.21
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Cannabis Strategic Ventures

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

833 South Spring, Los Angeles, CA, United States, 90014

310-359-6860

https://www.cannabisstrategic.com

30

Name Title Year Born
Mr. Simon Yu M.B.A. Chief Exec. Officer 1982
Paul Hutchin Pres NA
Ms. Arlene Guzman VP of Operations NA
Mr. John Vu Legal Counsel NA
J. Brown Sec. and Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…